Beyond BMI: Using AI-Based Phenotyping to Understand GLP-1 Treatment Outcomes Across the Patient Journey
Time: 4:45 pm
day: Conference Day One
Details:
- Identifying positive and negative impacts of GLP-1 treatment across organ systems using real-world data
- Using AI-based digital phenotyping to isolate distinct patient profiles based on likely outcomes, before and during treatment
- Assessing the balance among different treatment effects for personalized decision-making
